Jiangsu Hengrui Pharmaceuticals (01276) recommends adopting the A-share employee stock ownership plan for 2025.
Hengrui Medicine (01276) announced that it has approved at the board meeting held on August 20, 2025...
Jiangsu Hengrui Pharmaceuticals (01276) announced that its employee stock ownership plan was approved at the board meeting held on August 20, 2025. The employee stock ownership plan is subject to approval by the company's shareholders' meeting before it can take effect.
Related Articles
US Stock Market Move | Target Corporation (TGT.US) falls more than 7% as "CEO internal succession" plan disappoints the market.
Asian Capital "Looking Inwards": China and India Lead the Way, $22 Trillion Market Hides These Opportunities
US Stock Market Move | Some of the holders of shares are short-term support. SharpLink Gaming (SBET.US) rose more than 5.7%.
US Stock Market Move | Target Corporation (TGT.US) falls more than 7% as "CEO internal succession" plan disappoints the market.
Asian Capital "Looking Inwards": China and India Lead the Way, $22 Trillion Market Hides These Opportunities
US Stock Market Move | Some of the holders of shares are short-term support. SharpLink Gaming (SBET.US) rose more than 5.7%.
RECOMMEND
U.S. Tariff Revenue Set to Top $300 Billion This Year? Treasury Secretary Emphasizes Debt Repayment
20/08/2025
Weekend Shake-Up: Trump Administration Abruptly Expands Steel and Aluminum Tariff Scope, U.S. Importers Struggle to Comply
20/08/2025
H20 Still Under Scrutiny as NVIDIA Prepares New China-Specific Chip
20/08/2025
